A new trading day began on Tuesday, with Terns Pharmaceuticals Inc (NASDAQ: TERN) stock price down -5.22% from the previous day of trading, before settling in for the closing price of $8.43. TERN’s price has ranged from $1.87 to $8.78 over the past 52 weeks.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 16.38%. Meanwhile, its annual earnings per share averaged -2.40%. With a float of $69.58 million, this company’s outstanding shares have now reached $87.47 million.
Considering the fact that the conglomerate employs 59 people, you should pay attention to its efficiency factor.
Terns Pharmaceuticals Inc (TERN) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Terns Pharmaceuticals Inc is 20.49%, while institutional ownership is 83.04%. The most recent insider transaction that took place on Oct 01 ’25, was worth 7,407. In this transaction Chief Medical Officer of this company sold 944 shares at a rate of $7.85, taking the stock ownership to the 51,520 shares. Before that another transaction happened on Jul 01 ’25, when Company’s Chief Medical Officer sold 853 for $4.27, making the entire transaction worth $3,640. This insider now owns 52,464 shares in total.
Terns Pharmaceuticals Inc (TERN) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.28 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -2.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -8.40% during the next five years compared to 16.38% growth over the previous five years of trading.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Trading Performance Indicators
Here are Terns Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 24.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.05, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.26 in one year’s time.
Technical Analysis of Terns Pharmaceuticals Inc (TERN)
Compared to the last year’s volume of 1.16 million, its volume of 1.18 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 70.33%.
During the past 100 days, Terns Pharmaceuticals Inc’s (TERN) raw stochastic average was set at 87.10%, which indicates a significant increase from 48.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.46 in the past 14 days, which was higher than the 0.36 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.02, while its 200-day Moving Average is $4.70. Nevertheless, the first resistance level for the watch stands at $8.29 in the near term. At $8.60, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.75. If the price goes on to break the first support level at $7.83, it is likely to go to the next support level at $7.68. Should the price break the second support level, the third support level stands at $7.37.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Key Stats
With a market capitalization of 699.21 million, the company has a total of 87,511K Shares Outstanding. Currently, annual sales are 0 K while annual income is -88,850 K. The company’s previous quarter sales were 0 K while its latest quarter income was -24,090 K.
